Autopsy report · NCT00060385

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“low accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months after it had already started.
3 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2, Phase 3
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sponsor type: University, hospital or other
Conditions: Lymphoma
Interventions: CHOP regimen; EPOCH regimen; cyclophosphamide; doxorubicin hydrochloride; etoposide; prednisone
Participants: 3
Sites: 1
Countries: Belgium

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.